Kazia Therapeutics (KZIA) Assets (2017 - 2025)

Kazia Therapeutics' Assets history spans 6 years, with the latest figure at $3.9 million for Q2 2025.

  • For Q2 2025, Assets fell 72.71% year-over-year to $3.9 million; the TTM value through Jun 2025 reached $62.6 million, changed N/A, while the annual FY2025 figure was $3.9 million, 72.71% down from the prior year.
  • Assets reached $3.9 million in Q2 2025 per KZIA's latest filing, down from $14.2 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $25.7 million in Q2 2022 to a low of $3.9 million in Q2 2025.
  • Average Assets over 4 years is $15.6 million, with a median of $16.5 million recorded in 2023.
  • Peak YoY movement for Assets: dropped 24.21% in 2024, then crashed 72.71% in 2025.
  • A 4-year view of Assets shows it stood at $25.7 million in 2022, then fell by 26.98% to $18.8 million in 2023, then fell by 24.21% to $14.2 million in 2024, then plummeted by 72.71% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Assets are $3.9 million (Q2 2025), $14.2 million (Q2 2024), and $18.8 million (Q2 2023).